Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
Enabling automated, non-destructive inspection ensures consistent quality and maximizes value TOKYO, April 10, 2025 /PRNewswire/ -- Fujitsu Limited and Sonofai Inc., Ishida Tec...
New facility enhances supply chain security, reduces lead times and supports customers' growth First in Asia equipped with advanced air knife coating technology...
Unleashing the First Themed Station: Total Domination, Engaging Every Customers! HONG KONG, April 10, 2025 /PRNewswire/ -- Bravo Media consistently offers premium advertising...
SHENZHEN, China, April 10, 2025 /PRNewswire/ -- As cross-border mobility between Hong Kong and Shenzhen reaches unprecedented efficiency, Conrad Shenzhen has emerged as a beacon...
